Immediate Impact
16 standout
Citing Papers
Cancer mRNA vaccines: clinical advances and future opportunities
2024 Standout
miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer
2023 Standout
Works of Paul R. Avery being referenced
Class II Major Histocompatibility Complex Expression and Cell Size Independently Predict Survival in Canine B-Cell Lymphoma
2011
Canine Lymphoproliferative Disease Characterized by Lymphocytosis: Immunophenotypic Markers of Prognosis
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Paul R. Avery | 380 | 109 | 210 | 163 | 19 | 483 | |
| Stephen J. Engler | 417 | 88 | 230 | 176 | 10 | 511 | |
| Andrea B. Flory | 392 | 53 | 245 | 159 | 20 | 433 | |
| Paul G. Greenlee | 315 | 65 | 210 | 149 | 17 | 527 | |
| Kristen Weishaar | 344 | 79 | 194 | 110 | 26 | 443 | |
| Louis Philippe De Lorimier | 406 | 51 | 212 | 143 | 12 | 499 | |
| B.E. Powers | 373 | 77 | 130 | 102 | 23 | 535 | |
| K. Ann Jeglum | 356 | 134 | 85 | 230 | 24 | 549 | |
| Nancy O. Brown | 386 | 33 | 157 | 153 | 16 | 554 | |
| D. Glen Esplin | 405 | 103 | 177 | 138 | 9 | 484 | |
| Beth Overley | 419 | 87 | 181 | 213 | 13 | 567 |
All Works
Loading papers...